Last reviewed · How we verify
NCT04104984
Detection of Preterm Labour by Cervical Length
EARLY_PHASE1 trial testing transvaginal ultrasound in Preterm Labour in 966 participants. Status unknown.
15 September 2021
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 966 |
| Start date | 15 February 2020 |
| Primary completion | 15 September 2021 |
| Estimated completion | 15 November 2021 |
Drugs / interventions tested
- transvaginal ultrasound
- Progesterone Vaginal Suppository — full drug profile →
- cervical cercalage
- digital vaginal exam
- abdominal ultrasound
- Tocolytic Agents — full drug profile →
Conditions studied
- Preterm Labour — all drugs for Preterm Labour →
Sponsor
Assiut University
Who can join
Adults 16 to 45, female only, with Preterm Labour. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Detection of short cervix by transvaginal ultrasound and its evidence based management to prevent preterm birth .
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04104984
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of transvaginal ultrasound
Trials testing the same drug.
- NCT06888414 — Evaluation of the Uterine Cavity in Perimenopausal Women. · active not recruiting
- NCT05691322 — Prospective Validation of the DEVA Algorithm for the Prediction of Severe Endometriosis · unknown
- NCT03841916 — Relation Between Body Mass Index and Endometrial Thickness · unknown
- NCT04665414 — Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI · completed
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04104984 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 14 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04104984.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing